These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. Leclerc E; Fritz G; Weibel M; Heizmann CW; Galichet A J Biol Chem; 2007 Oct; 282(43):31317-31. PubMed ID: 17726019 [TBL] [Abstract][Full Text] [Related]
10. S100B expression modulates left ventricular remodeling after myocardial infarction in mice. Tsoporis JN; Marks A; Haddad A; Dawood F; Liu PP; Parker TG Circulation; 2005 Feb; 111(5):598-606. PubMed ID: 15699280 [TBL] [Abstract][Full Text] [Related]
11. S100B protein in tissue development, repair and regeneration. Sorci G; Riuzzi F; Arcuri C; Tubaro C; Bianchi R; Giambanco I; Donato R World J Biol Chem; 2013 Feb; 4(1):1-12. PubMed ID: 23580916 [TBL] [Abstract][Full Text] [Related]
12. S100B Protein, A Damage-Associated Molecular Pattern Protein in the Brain and Heart, and Beyond. Sorci G; Bianchi R; Riuzzi F; Tubaro C; Arcuri C; Giambanco I; Donato R Cardiovasc Psychiatry Neurol; 2010; 2010():. PubMed ID: 20827421 [TBL] [Abstract][Full Text] [Related]
13. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis. Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587 [TBL] [Abstract][Full Text] [Related]
14. Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases. Chong ZZ; Changyaleket B; Xu H; Dull RO; Schwartz DE Curr Med Chem; 2016; 23(15):1571-96. PubMed ID: 27048377 [TBL] [Abstract][Full Text] [Related]
15. S100B promotes injury-induced vascular remodeling through modulating smooth muscle phenotype. Cao T; Zhang L; Yao LL; Zheng F; Wang L; Yang JY; Guo LY; Li XY; Yan YW; Pan YM; Jiang M; Chen L; Tang JM; Chen SY; Wang JN Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2772-2782. PubMed ID: 28693920 [TBL] [Abstract][Full Text] [Related]
16. Structural insights into the interaction of human S100B and basic fibroblast growth factor (FGF2): Effects on FGFR1 receptor signaling. Gupta AA; Chou RH; Li H; Yang LW; Yu C Biochim Biophys Acta; 2013 Dec; 1834(12):2606-19. PubMed ID: 24063890 [TBL] [Abstract][Full Text] [Related]
17. S100B is required for high glucose-induced pro-fibrotic gene expression and hypertrophy in mesangial cells. Chuang CT; Guh JY; Lu CY; Chen HC; Chuang LY Int J Mol Med; 2015 Feb; 35(2):546-52. PubMed ID: 25482070 [TBL] [Abstract][Full Text] [Related]
18. S100B protein activates a RAGE-dependent autocrine loop in astrocytes: implications for its role in the propagation of reactive gliosis. Villarreal A; Seoane R; González Torres A; Rosciszewski G; Angelo MF; Rossi A; Barker PA; Ramos AJ J Neurochem; 2014 Oct; 131(2):190-205. PubMed ID: 24923428 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of receptor for advanced glycation end products induces monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cell line. Hayakawa E; Yoshimoto T; Sekizawa N; Sugiyama T; Hirata Y J Atheroscler Thromb; 2012; 19(1):13-22. PubMed ID: 22082983 [TBL] [Abstract][Full Text] [Related]
20. Circulating Ligands of the Receptor for Advanced Glycation End Products and the Soluble Form of the Receptor Modulate Cardiovascular Cell Apoptosis in Diabetes. Tsoporis JN; Hatziagelaki E; Gupta S; Izhar S; Salpeas V; Tsiavou A; Rigopoulos AG; Triantafyllis AS; Marshall JC; Parker TG; Rizos IK Molecules; 2020 Nov; 25(22):. PubMed ID: 33182705 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]